Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway

被引:291
作者
Shiojima, Ichiro [1 ]
Walsh, Kenneth
机构
[1] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
[2] Chiba Univ, Sch Med, Dept Cardiovasc Sci & Med, Chiba 2608670, Japan
关键词
Akt; hypertrophy; heart failure; angiogenesis; mTOR;
D O I
10.1101/gad.1492806
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Postnatal growth of the heart is primarily achieved through hypertrophy of individual myocytes. Cardiac growth observed in athletes represents adaptive or physiological hypertrophy, whereas cardiac growth observed in patients with hypertension or valvular heart diseases is called maladaptive or pathological hypertrophy. These two types of hypertrophy are morphologically, functionally, and molecularly distinct from each other. The serine/threonine protein kinase Akt is activated by various extracellular stimuli in a phosphatidylinositol-3 kinase-dependent manner and regulates multiple aspects of cellular functions including survival, growth and metabolism. In this review we will discuss the role of the Akt signaling pathway in the heart, focusing on the regulation of cardiac growth, contractile function, and coronary angiogenesis. How this signaling pathway contributes to the development of physiological/pathological hypertrophy and heart failure will also be discussed.
引用
收藏
页码:3347 / 3365
页数:19
相关论文
共 190 条
  • [1] Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis
    Ackah, E
    Yu, J
    Zoellner, S
    Iwakiri, Y
    Skurk, C
    Shibata, R
    Ouchi, N
    Easton, RM
    Galasso, G
    Birnbaum, MJ
    Walsh, K
    Sessa, WC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) : 2119 - 2127
  • [2] Delayed mammary gland involution in MMTV-AKT1 transgenic mice
    Ackler, S
    Ahmad, S
    Tobias, C
    Johnson, MD
    Glazer, RI
    [J]. ONCOGENE, 2002, 21 (02) : 198 - 206
  • [3] RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development
    Adini, I
    Rabinovitz, I
    Sun, JF
    Prendergast, GC
    Benjamin, LE
    [J]. GENES & DEVELOPMENT, 2003, 17 (21) : 2721 - 2732
  • [4] Perturbations of the AKT signaling pathway in human cancer
    Altomare, DA
    Testa, JR
    [J]. ONCOGENE, 2005, 24 (50) : 7455 - 7464
  • [5] Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
    An, Ding
    Rodrigues, Brian
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (04): : H1489 - H1506
  • [6] Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors
    Andjelkovic, M
    Jakubowicz, T
    Cron, P
    Ming, XF
    Han, JW
    Hemmings, BA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 5699 - 5704
  • [7] Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
    Antos, CL
    McKinsey, TA
    Frey, N
    Kutschke, W
    McAnally, J
    Shelton, JM
    Richardson, JA
    Hill, JA
    Olson, EN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) : 907 - 912
  • [8] Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response
    Aoyama, T
    Matsui, T
    Novikov, M
    Park, J
    Hemmings, B
    Rosenzweig, A
    [J]. CIRCULATION, 2005, 111 (13) : 1652 - 1659
  • [9] Glycogen synthase kinase 3β inhibits myocardin dependent transcription and hypertrophy induction through site-specific phosphorylation
    Badorff, C
    Seeger, FH
    Zeiher, AM
    Dimmeler, S
    [J]. CIRCULATION RESEARCH, 2005, 97 (07) : 645 - 654
  • [10] FoxO proteins in insulin action and metabolism
    Barthel, A
    Schmoll, D
    Unterman, TG
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (04) : 183 - 189